Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.45 |
| ▸ | NOD1 | Q9Y239 | 4/20 | 0.45 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.42 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.41 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | FAAH | O00519 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28808814 | 1.00 | KMT2A (0.47) | KMT2AHDAC6NOD1HDAC1POLB | |
| SCHEMBL30401325 | 0.94 | SLC6A5 (0.52) | KMT2ASLC6A5FAAH | |
| SCHEMBL27926541 | 0.92 | HDAC6 (0.54) | HDAC6HDAC1SLC6A5 | |
| SCHEMBL18796598 | 0.92 | HDAC6 (0.54) | HDAC6HDAC1SLC6A5 | |
| SCHEMBL23250545 | 0.88 | LMNA (0.42) | KMT2AHDAC6NOD1HDAC1SLC6A5 | |
| SCHEMBL27199087 | 0.88 | LMNA (0.42) | KMT2AHDAC6NOD1HDAC1SLC6A5 | |
| SCHEMBL23250523 | 0.88 | LMNA (0.42) | KMT2AHDAC6NOD1HDAC1SLC6A5 | |
| SCHEMBL9664377 | 0.87 | SLC6A5 (0.54) | KMT2ANOD1SLC6A5ITGB3ITGA2B | |
| SCHEMBL9665935 | 0.87 | SLC6A5 (0.54) | KMT2ANOD1SLC6A5ITGB3ITGA2B | |
| SCHEMBL13279668 | 0.87 | SLC6A5 (0.54) | KMT2ANOD1SLC6A5ITGB3ITGA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9284265-B1 | Preparation of organic acid salts of cationic surfactants | GHARE VISHWAS SADHU (IN) | 2016-03-15 | — | — | US | claimed |
| US-20120328544-A1 | Dermatological Treatment Methods And Formulations | Nevada Naturals, Inc. (US) | 2012-12-27 | — | — | US | claimed |
| US-8212061-B1 | Preparation of organic acid salts of cationic surfactants | GHARE VISHWAS SADHU (IN) | 2012-07-03 | — | — | US | claimed |
| US-20090318557-A1 | Dermatological compositions | STOCKEL RICHARD F | 2009-12-24 | — | — | US | claimed |
| US-9284265-B1 | Preparation of organic acid salts of cationic surfactants | GHARE VISHWAS SADHU (IN) | 2016-03-15 | — | — | US | disclosed |
| US-20120328544-A1 | Dermatological Treatment Methods And Formulations | Nevada Naturals, Inc. (US) | 2012-12-27 | — | — | US | disclosed |
| US-8212061-B1 | Preparation of organic acid salts of cationic surfactants | GHARE VISHWAS SADHU (IN) | 2012-07-03 | — | — | US | disclosed |
| US-20090318557-A1 | Dermatological compositions | STOCKEL RICHARD F | 2009-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090318557-A1 | Dermatological compositions | MTX1, CD68, GRN | KMT2A 3441/4885HDAC6 944/4885NOD1 99/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.